Our CEO Agnes Arbat is interviewed at IB radio to talk about our OXOART2 Clinical trial. She explains the potential of OXO-001 as a treatment for female infertility and which women can participate in this study in leading centers such as IVI RMA GLOBAL (Mallorca, Valencia, Madrid, Barcelona, Sevilla, Bilbao, Zaragoza), Ginemed (Sevilla), Quirónsalud (Barcelona, Madrid), Dexeus mujer (Barcelona), Fertty (Barcelona), Instituto Bernabeu (Madrid, Alicante) y Clínica Ginefiv (Madrid).
Media: https://ib3.org/ajornament-maternitat-quan-ser-mama-depen-proces-in-vitro
Audio: https://ib3.org/informatiu-radio-migdia?pl=1&cont=bf5df4a8-aeba-40ca-bac4-b8c1cb1dc24e&t=2940,3000 (min 49:30)